Prototype

Valuation proposition...

How will the 2 billion that are illiterate use the mobile devices to communicate, interact and learn? How will your 2 year old learn? Or how will your grandparents find out what you have done or are doing on Twitter, Facebook, Youtube, etc... without going there!? Simple... Wikitube.TV. Our goal is to provide a very personalized one-stop-shop for all your multimedia viewing(videos and photos), gathering, mixing, and saving EVERY multimedia... and do it all from just one location!?

Answer...

http://www.WIKITUBE.TV

Groups International LLC is the parent company to three diversified companies that provide services to the managed and unmanaged group travel markets.

iGroupManagement is a Full-Service Group Travel Management Company that provide services to companies and organizations that plan or facilitate meetings, conferences, incentive travel programs, sports, team, school and other managed group events.

iGroupMeetings is an online resource for those who plan meetings, conferences and other related group movements that consist of a minimum of 10 guest rooms.

LuxRay Dental provides dentists with a low cost and easy to use dental imaging system which can accurately detect cavities and pre-cavity conditions. The LuxRay system uses infrared light which is significantly more accurate in cavities detection than current methods of X-Rays or dental explorers (metal pick). In addition, the LuxRay system provides real time images which can create a full 3D model of a tooth.

AMES, a spinoff of Oregon Health & Sciences University, is bringing to market within the next 18 months, a new non-invasive 510K Class II medical device and methodology (qualifying for reimbursement), which it believes to be the most significant scientific and medical breakthrough for stroke and brain-injured patients in the last 25 years.

The Company has already demonstrated the efficacy of AMES ® therapy in a published study on chronic stroke patients over 1 year post-stroke, and is currently conducting a nationwide trial on sub-acute stroke patients (less than 6 months post-stroke).